http://www.thehamner.org/news-events/entry/the-hamner-institutes-for-health-sciences-announces-formation-of-dili-sim-i
"The Hamner Institutes for Health Sciences (The Hamner) has announced the formation of the DILI-sim Initiative, a pre-competitive partnership between The Hamner and a diverse set of stakeholders to develop a computational model that will predict whether new drug candidates will cause drug-induced liver injury (DILI) in patients. The goals of the Initiative are to improve patient safety, reduce the need for animal testing, and reduce the costs and time necessary to develop new drugs. It is the intent of the DILI-sim Initiative to make the model, in the form of DILIsymTM software, broadly available so that it may be used by the pharmaceutical industry, the U.S. Food and Drug Administration (FDA), and other entities in academia, government and industry."
http://www.thehamner.org/institutes-centers/institute-for-drug-safety-sciences/dili-sim-initiative/
http://www.thehamner.org/content/Hamner_DILI-sim_Flyer.pdf
